Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Diana Hausman Insider Profile
4 Followers
Diana Hausman, CMO at Cascadian Therapeutics, holds 5.72K shares in Zymeworks (Ticker: ZYME), holds 5.75K shares in Cascadian Therapeutics (Ticker: CASC).
Diana Hausman Cascadian Therapeutics (CASC)CMO
Cascadian Therapeutics (CASC)
CMO
Not Ranked
Diana Hausman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CMO
Roles that Diana Hausman holds in companies
Most Profitable Insider Trade
Stock:
Cascadian Therapeutics
(CASC)
(CASC)
Rating:Informative Buy
Date:Jun 03, 2015 - Jun 03, 2016
Return:-72.30%
The most profitable trade made by Diana Hausman
Diana Hausman's Trading History
Cascadian Therapeutics
Jun 03, 2015
―
Informative Buy
26.72K
$57.58K
Zymeworks
Sep 16, 2020
CMO
Uninformative Sell
1.80M
$285.10K
List of latest transactions for each holding click on a transaction to see Diana Hausman's performance on stock
You May Also Like
Diana Hausman insider profile FAQ
What is the percentage of profitable transactions made by Diana Hausman?
The percentage of profitable transactions made by Diana Hausman is ―.
What is the average return per transaction made by Diana Hausman?
The average return per transaction made by Diana Hausman is ―.
What stocks does Diana Hausman hold?
Diana Hausman holds: CASC, ZYME stocks.
What was Diana Hausman’s latest transaction?
Diana Hausman latest transaction was an Uninformative Sell of $1.80M.
What was Diana Hausman's most profitable transaction?
Diana Hausman’s most profitable transaction was an Informative Buy of CASC stock on June 3, 2015. The return on the trade was -72.30%.
What is Diana Hausman's role in Cascadian Therapeutics?
Diana Hausman's role in Cascadian Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.